#1 Clinical Trials Search in Europe

Sulfur Hexafluoride

Sulfur hexafluoride is being studied in various clinical trials as a contrast agent to enhance medical imaging techniques, particularly ultrasound. This article explores how this compound is being used to improve diagnostic accuracy and guide treatments across different medical conditions, from cardiovascular issues to cancer detection.

Table of Contents

What is Sulfur Hexafluoride?

Sulfur hexafluoride is a medical imaging agent used to enhance ultrasound images. It’s also known by several other names, including:

  • SonoVue
  • Lumason
  • Sulphur hexafluoride lipid-type A microspheres
These names may appear on your medical records or prescriptions, but they all refer to the same substance.[1][2]

Medical Uses

Sulfur hexafluoride is used in a medical imaging technique called contrast-enhanced ultrasound (CEUS). This technique helps doctors see inside your body more clearly than with regular ultrasound. It’s used to examine various parts of the body, including:

  • Liver: To detect and characterize liver lesions (abnormal areas in the liver)[3]
  • Heart: To improve the visibility of the heart’s inner lining during echocardiography (an ultrasound of the heart)[1]
  • Blood vessels: To examine blood flow in various parts of the body, including the carotid arteries in the neck[4]
  • Breast: To help differentiate between benign (non-cancerous) and malignant (cancerous) breast lesions[5]
  • Prostate: To aid in the detection and localization of prostate cancer[6]
  • Brain: To evaluate brain perfusion (blood flow) in infants with suspected brain injury[2]

How It Works

Sulfur hexafluoride works by forming tiny bubbles called microbubbles. These microbubbles are smaller than red blood cells and can easily travel through your bloodstream. When exposed to ultrasound waves, these bubbles vibrate and produce a strong echo, making blood vessels and organs more visible on the ultrasound image.[2]

This enhanced visibility allows doctors to:

  • See the structure of organs more clearly
  • Observe blood flow patterns
  • Detect abnormalities that might not be visible with regular ultrasound

Administration

Sulfur hexafluoride is given as an injection into a vein (intravenously). The dose is usually based on your weight. For most applications, the typical dose is 0.03 mL per kilogram of body weight. Sometimes, a second injection may be given during the same examination to ensure good image quality.[7][2]

The imaging procedure usually takes about 15 minutes, but you may be monitored for up to an hour after the injection to ensure you don’t have any adverse reactions.[2]

Safety and Side Effects

Sulfur hexafluoride has been used safely in many patients, including children. It’s considered to have an excellent safety profile. Unlike some other imaging agents, it’s not processed by the kidneys, making it safe for people with kidney problems.[6]

Side effects are generally rare and mild. However, as with any medical procedure, there’s always a small risk of allergic reactions. Your healthcare team will monitor you closely during and after the procedure.[1]

Ongoing Research

Researchers are continually exploring new ways to use sulfur hexafluoride to improve medical imaging and patient care. Some areas of ongoing research include:

  • COVID-19: Investigating how CEUS can help detect blood flow problems in various organs of patients with COVID-19[7]
  • Brain injury in newborns: Using CEUS to evaluate brain blood flow in infants with suspected hypoxic-ischemic injury (brain damage due to lack of oxygen)[2]
  • Prostate cancer: Developing new ways to use CEUS to improve prostate cancer detection and diagnosis[6]

These studies aim to expand the use of sulfur hexafluoride and improve its effectiveness in diagnosing and monitoring various medical conditions.

Aspect Details
Primary Use Contrast agent for ultrasound imaging
Formulation Microbubbles of sulfur hexafluoride gas
Administration Intravenous injection
Key Applications Cardiovascular imaging, liver lesion characterization, tumor detection, perfusion assessment
Advantages Real-time imaging, no radiation, bedside examination capability
Safety Profile Generally well-tolerated with minimal reported side effects
Ongoing Research Pediatric echocardiography, COVID-19 complications, prostate cancer detection

FAQ

  • What is sulfur hexafluoride and how is it used in medical imaging? Sulfur hexafluoride is a gas that can be formulated into microbubbles for use as an ultrasound contrast agent. When injected into the bloodstream, it enhances the visibility of blood flow and tissue structures during ultrasound imaging, allowing for clearer and more detailed scans.
  • What medical conditions are being studied using sulfur hexafluoride contrast? Clinical trials are exploring the use of sulfur hexafluoride contrast in various conditions, including cardiovascular diseases, liver lesions, breast tumors, prostate cancer, and even COVID-19-related complications in children.
  • Is sulfur hexafluoride safe for use in patients? Sulfur hexafluoride has shown a good safety profile in clinical trials. It is generally well-tolerated, with minimal side effects reported. However, as with any medical procedure, its use is carefully monitored and evaluated for each patient.
  • How does contrast-enhanced ultrasound compare to other imaging techniques? Contrast-enhanced ultrasound using sulfur hexafluoride offers several advantages, including real-time imaging, no radiation exposure, and the ability to perform bedside examinations. In some studies, it has shown comparable or even superior results to other imaging modalities like MRI or CT scans for certain applications.
  • What are the potential benefits of using sulfur hexafluoride in clinical practice? The use of sulfur hexafluoride as a contrast agent can potentially improve diagnostic accuracy, aid in the characterization of tumors and lesions, enhance the evaluation of blood flow and perfusion, and guide treatment decisions. It may also reduce the need for more invasive diagnostic procedures in some cases.

Ongoing Clinical Trials on Sulfur Hexafluoride

  • Study Comparing Apixaban and Warfarin for Patients with Heart Clots After a Heart Attack

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Sweden

  • Title: Study of ultrasound-assisted carboplatin therapy with SonoVue for children with recurrent malignant brain tumors using blood-brain barrier disruption

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Early Use of Vasopressin and Norepinephrine for Patients with Septic Shock

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Placental Blood Flow in Fetal Growth Restriction Using Sulfur Hexafluoride for Patients Undergoing Medical Termination of Pregnancy

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Use of Sulfur Hexafluoride in Ultrasound for Diagnosing Adnexal Torsion in Patients with Suspected Ovarian Twisting

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study on Newborn Brain Conditions Using Sulfur Hexafluoride Ultrasound for Babies with Hypoxic-Ischemic Injury, Stroke, or Infections

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Finland

  • Study on Diagnosing Vesicoureteral Reflux in Children Using Sulfur Hexafluoride and Technetium (99mTc)

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Finland

Glossary

  • Contrast agent: A substance used to enhance the visibility of internal body structures in medical imaging techniques.
  • Microbubbles: Tiny bubbles of gas encapsulated in a lipid shell, used as contrast agents in ultrasound imaging.
  • Endocardial border delineation: The process of clearly defining the inner lining of the heart chambers during cardiac imaging.
  • Focal liver lesion: An area of tissue in the liver that looks different from the surrounding liver tissue on imaging.
  • Neovascularization: The formation of new blood vessels, often associated with tumor growth or inflammation.
  • Proliferative vitreoretinopathy: A complication of retinal detachment where scar tissue forms on the surface of the retina.
  • Keratoconus: A condition where the cornea of the eye thins and bulges outward into a cone shape.
  • Multiparametric ultrasound: An advanced ultrasound technique that combines different ultrasound parameters to improve diagnostic accuracy.
  • Hepatobiliary: Relating to the liver, gallbladder, and bile ducts.
  • Microvascular perfusion: The blood flow through the smallest blood vessels in the body's tissues.

References

  1. https://clinicaltrials.gov/study/NCT02282163
  2. https://clinicaltrials.gov/study/NCT03549520
  3. https://clinicaltrials.gov/study/NCT00829413
  4. https://clinicaltrials.gov/study/NCT00677963
  5. https://clinicaltrials.gov/study/NCT00243698
  6. https://clinicaltrials.gov/study/NCT03101176
  7. https://clinicaltrials.gov/study/NCT04640038